Detalhe da pesquisa
1.
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.
Cancer Immunol Immunother
; 69(3): 421-434, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31919623